Since RAB proteins have been proposed as new therapeutic targets in cancer22, our results suggest that the down-regulation of a subset of RAB family members in cancer tissues could restore the activity of the PP2A tumor suppressor. The gene discussed is PTPA; the disease is neoplasm.